25 related articles for article (PubMed ID: 31899468)
1. A proteomic approach supports the clinical relevance of TAT-Cx43
Pelaz SG; Flores-Hernández R; Vujic T; Schvartz D; Álvarez-Vázquez A; Ding Y; García-Vicente L; Belloso A; Talaverón R; Sánchez JC; Tabernero A
Transl Res; 2024 Jun; ():. PubMed ID: 38876188
[TBL] [Abstract][Full Text] [Related]
2. Towards multi-target glioblastoma therapy: Structural, distribution, and functional insights into protein target candidates.
Anas E; Hoover E; Ille AL; Ille AM; Amico-Ruvio S
Brain Res; 2024 Jan; 1822():148623. PubMed ID: 37820848
[TBL] [Abstract][Full Text] [Related]
3. Papillary Thyroid Cancer Remodels the Genetic Information Processing Pathways.
Iacobas DA; Iacobas S
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790250
[TBL] [Abstract][Full Text] [Related]
4. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
5. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
6. How do oncoprotein mutations rewire protein-protein interaction networks?
Bowler EH; Wang Z; Ewing RM
Expert Rev Proteomics; 2015; 12(5):449-55. PubMed ID: 26325016
[TBL] [Abstract][Full Text] [Related]
7. Proteomics and molecular network analyses reveal that the interaction between the TAT-DCF1 peptide and TAF6 induces an antitumor effect in glioma cells.
Wang J; Wang F; Li Q; Wang Q; Li J; Wang Y; Sun J; Lu D; Zhou H; Li S; Ma S; Xie J; Wen T
Mol Omics; 2020 Feb; 16(1):73-82. PubMed ID: 31899468
[TBL] [Abstract][Full Text] [Related]
8. The antitumor effect of TAT-DCF1 peptide in glioma cells.
Wang J; Wang Q; Zhou F; Li J; Li Q; Zhou H; Li S; Ma S; Wen T
Neuropeptides; 2018 Oct; 71():21-31. PubMed ID: 30001801
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of DCF1 inhibits glioma through destruction of mitochondria and activation of apoptosis pathway.
Xie Y; Li Q; Yang Q; Yang M; Zhang Z; Zhu L; Yan H; Feng R; Zhang S; Huang C; Liu Z; Wen T
Sci Rep; 2014 Jan; 4():3702. PubMed ID: 24424470
[TBL] [Abstract][Full Text] [Related]
10. Interaction of DCF1 with ATP1B1 induces impairment in astrocyte structural plasticity via the P38 signaling pathway.
Wang J; Zhou F; Wang D; Li J; Lu D; Li Q; Zhou H; Li W; Wang Q; Wu Y; Xie J; Wen T
Exp Neurol; 2018 Apr; 302():214-229. PubMed ID: 29337145
[TBL] [Abstract][Full Text] [Related]
11. Dcf1 induces glioblastoma cells apoptosis by blocking autophagy.
Luo G; Feng R; Li W; Chen Y; Sun Y; Ma J; Duo Y; Wen T
Cancer Med; 2022 Jan; 11(1):207-223. PubMed ID: 34799992
[TBL] [Abstract][Full Text] [Related]
12. The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.
Song J; Ma Q; Hu M; Qian D; Wang B; He N
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544723
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
